Showing results (2891-2900 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|December 7, 2007
Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200A Siva, H Xin, F Qin, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2007
In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1Claudia Gravekamp, Belinda Leal, Ashley Denny, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2007
CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patientsXiaorong Lin, Nancy H Gudgeon, Edwin P Hui, et al.
Cancer Immunology, Immunotherapy : CII|December 7, 2007
Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAFNobuto Yamamoto, Hirofumi Suyama, Hiroaki Nakazato, et al.
Cancer Immunology, Immunotherapy : CII|December 7, 2007
Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functionsJennifer K Mulligan, Deanne M R Lathers, M Rita I Young
Cancer Immunology, Immunotherapy : CII|February 18, 2006
Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligandsRafael Solana, Javier G Casado, Elena Delgado, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2006
Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomasMichael J Ciesielski, Lisa Apfel, Tara A Barone, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2006
Complement decay accelerating factor (DAF)/CD55 in cancerIan Spendlove, Judith M Ramage, Richard Bradley, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Monocyte-dependent, serum-borne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patientsK Itoh, N R Pellis, C M Balch
Cancer Immunology, Immunotherapy : CII|November 19, 2016
A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agentsSylvia Herter, Laura Morra, Ramona Schlenker, et al.
Pageof 652